226 related articles for article (PubMed ID: 27001088)
21. Assessing the prevalence of PINK1 genetic variants in South African patients diagnosed with early- and late-onset Parkinson's disease.
Keyser RJ; Lesage S; Brice A; Carr J; Bardien S
Biochem Biophys Res Commun; 2010 Jul; 398(1):125-9. PubMed ID: 20558144
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
[TBL] [Abstract][Full Text] [Related]
23. Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population.
Nuytemans K; Meeus B; Crosiers D; Brouwers N; Goossens D; Engelborghs S; Pals P; Pickut B; Van den Broeck M; Corsmit E; Cras P; De Deyn PP; Del-Favero J; Van Broeckhoven C; Theuns J
Hum Mutat; 2009 Jul; 30(7):1054-61. PubMed ID: 19405094
[TBL] [Abstract][Full Text] [Related]
24. PARK2 gene mutations in early onset Parkinson's disease patients of South India.
Padmaja MV; Jayaraman M; Srinivasan AV; Srisailapathy CR; Ramesh A
Neurosci Lett; 2012 Aug; 523(2):145-7. PubMed ID: 22766139
[TBL] [Abstract][Full Text] [Related]
25. Low prevalence of most frequent pathogenic variants of six PARK genes in sporadic Parkinson's disease.
García S; López-Hernández LB; Suarez-Cuenca JA; Solano-Rojas M; Gallegos-Arreola MP; Gama-Moreno O; Valdez-Anguiano P; Canto P; Dávila-Maldonado L; Cuevas-García CF; Coral-Vázquez RM
Folia Neuropathol; 2014; 52(1):22-9. PubMed ID: 24729340
[TBL] [Abstract][Full Text] [Related]
26. Clinical findings and genetic screening for copy number variation mutations in a cohort of South African patients with Parkinson's disease.
Mahne AC; Carr JA; Bardien S; Schutte CM
S Afr Med J; 2016 May; 106(6):. PubMed ID: 27245731
[TBL] [Abstract][Full Text] [Related]
27. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.
Mellick GD; Siebert GA; Funayama M; Buchanan DD; Li Y; Imamichi Y; Yoshino H; Silburn PA; Hattori N
Parkinsonism Relat Disord; 2009 Feb; 15(2):105-9. PubMed ID: 18486522
[TBL] [Abstract][Full Text] [Related]
28. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
[TBL] [Abstract][Full Text] [Related]
29. Heterozygote carriers for CNVs in PARK2 are at increased risk of Parkinson's disease.
Huttenlocher J; Stefansson H; Steinberg S; Helgadottir HT; Sveinbjörnsdóttir S; Riess O; Bauer P; Stefansson K
Hum Mol Genet; 2015 Oct; 24(19):5637-43. PubMed ID: 26188007
[TBL] [Abstract][Full Text] [Related]
30. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
31. Genetic study of early-onset Parkinson's disease in the Malaysian population.
Tay YW; Tan AH; Lim JL; Lohmann K; Ibrahim KA; Abdul Aziz Z; Chin YT; Mawardi AS; Lim TT; Looi I; Chia YK; Ooi JCE; Cheah WK; Dy Closas AMF; Lit LC; Hor JW; Toh TS; Muthusamy KA; Bauer P; Skrahin V; Rolfs A; Klein C; Ahmad-Annuar A; Lim SY
Parkinsonism Relat Disord; 2023 Jun; 111():105399. PubMed ID: 37209484
[TBL] [Abstract][Full Text] [Related]
32. Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease.
Koziorowski D; Hoffman-Zacharska D; Sławek J; Szirkowiec W; Janik P; Bal J; Friedman A
Parkinsonism Relat Disord; 2010 Feb; 16(2):136-8. PubMed ID: 19628420
[TBL] [Abstract][Full Text] [Related]
33. PRKN, DJ-1, and PINK1 screening identifies novel splice site mutation in PRKN and two novel DJ-1 mutations.
Ghazavi F; Fazlali Z; Banihosseini SS; Hosseini SR; Kazemi MH; Shojaee S; Parsa K; Sadeghi H; Sina F; Rohani M; Shahidi GA; Ghaemi N; Ronaghi M; Elahi E
Mov Disord; 2011 Jan; 26(1):80-9. PubMed ID: 21322020
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease.
Sinha R; Racette B; Perlmutter JS; Parsian A
Parkinsonism Relat Disord; 2005 Sep; 11(6):341-7. PubMed ID: 16019250
[TBL] [Abstract][Full Text] [Related]
35. Occurrence of PARK2 mutations in a never-smoker population with Parkinson's disease in North India.
Prabhakar S; Vinish M; Das CP; Anand A
Neuroepidemiology; 2010 Aug; 35(2):152-9. PubMed ID: 20571283
[TBL] [Abstract][Full Text] [Related]
36. Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.
Macedo MG; Verbaan D; Fang Y; van Rooden SM; Visser M; Anar B; Uras A; Groen JL; Rizzu P; van Hilten JJ; Heutink P
Mov Disord; 2009 Jan; 24(2):196-203. PubMed ID: 18973254
[TBL] [Abstract][Full Text] [Related]
37. Role of mendelian genes in "sporadic" Parkinson's disease.
Lesage S; Brice A
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S66-70. PubMed ID: 22166458
[TBL] [Abstract][Full Text] [Related]
38. Exon dosage analysis of parkin gene in Chinese sporadic Parkinson's disease.
Guo JF; Dong XL; Xu Q; Li N; Yan XX; Xia K; Tang BS
Neurosci Lett; 2015 Sep; 604():47-51. PubMed ID: 26240990
[TBL] [Abstract][Full Text] [Related]
39. Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.
Zhu W; Huang X; Yoon E; Bandres-Ciga S; Blauwendraat C; Billingsley KJ; Cade JH; Wu BP; Williams VH; Schindler AB; Brooks J; Gibbs JR; Hernandez DG; Ehrlich D; Singleton AB; Narendra DP
Brain; 2022 Jun; 145(6):2077-2091. PubMed ID: 35640906
[TBL] [Abstract][Full Text] [Related]
40. Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus.
Tatura R; Kraus T; Giese A; Arzberger T; Buchholz M; Höglinger G; Müller U
Parkinsonism Relat Disord; 2016 Dec; 33():115-121. PubMed ID: 27717584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
